AngioDynamics, Inc. (ANGO)

AngioDynamics Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Net Income	-27.71	-33.99	-184.35	-52.44	-26.55	-31.55
Depreciation & Amortization	23.92	25.8	27.71	30.87	29.35	25.92
Stock-Based Compensation	11.4	9.77	10.53	11.16	10.69	8.63
Other Adjustments	2.78	2.41	103.53	17.52	0.36	12.03
Change in Receivables	-1.46	0.02	7.89	-1.3	-17.15	-4.16
Changes in Inventories	0.48	-1.35	-9.41	-8.2	-2.8	11.54
Changes in Accounts Payable	-15.89	-15.88	27.53	2.14	3.91	4.88
Changes in Other Operating Activities	0.87	3.09	-11.59	0.33	-5.01	-3.18
Operating Cash Flow	-5.6	-10.13	-28.16	0.08	-7.19	24.09
Capital Expenditures	-8.98	-10.18	-7.53	-9.21	-15.71	-13.71
Sale of Property, Plant & Equipment	-	-	134.5	-	-	-
Purchases of Intangible Assets	-	-	-3.25	-0.54	-	-
Payments for Business Acquisitions	-	-	-	-	-3.6	-
Investing Cash Flow	-8.98	-10.18	123.72	-9.75	-19.31	-13.71
Long-Term Debt Issued	-	6.31	-	70	5	-
Long-Term Debt Repaid	-0.33	-0.15	-50	-45	-	-20
Net Long-Term Debt Issued (Repaid)	-0.33	6.16	-50	25	5	-20
Issuance of Common Stock	1.13	0.93	0.75	1.17	2.68	3.01
Repurchase of Common Stock	-	-1.67	-	-	-	-
Net Common Stock Issued (Repurchased)	1.13	-0.74	0.75	1.17	2.68	3.01
Other Financing Activities	-5.68	-5.68	-15	-0.75	-	-
Financing Cash Flow	1.43	-0.26	-64.25	25.42	7.68	-16.99
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.71	0.4	0.13	0.04	-0.52	0.33
Net Cash Flow	-12.45	-20.16	31.44	15.8	-19.34	-6.27
Free Cash Flow	-14.59	-20.31	-35.69	-9.13	-22.9	10.38
FCF Margin	-4.75%	-6.94%	-11.74%	-2.69%	-7.24%	3.57%
Free Cash Flow Per Share	-0.35	-0.50	-0.89	-0.23	-0.59	0.27
Levered Free Cash Flow	-27.65	-26.34	-207.64	-11.5	-11.8	-26.11
Unlevered Free Cash Flow	-26.02	-38.42	-158.41	-33.37	-15.49	-5.44

Updated Jan 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q